Gapping down
In reaction to earnings/guidance:
- BL -12.2%, CFLT -11.3%, UPWK -10.7%, AFRM -10.5%, CLF -7.3%, CC -6.6%, BARK -5.9% (also announces partnership with Walmart), NSP -4.7%, FRSH -4.6%, DXCM -3.9%, ACB -3.9%, ME -2.6%, PRO -2.1%, NBIX -2%, APO -1.8%, COUR -1.6%, BRKR -1.4%, GPRE -1.4%, UAA -1.3%, ELY -1.1%, SXT -1.1%, SSNC -1%, VCRA -1%, MGA -1%, ILMN -0.9%, URBN -0.9%
Other news:
- PRQR -66.8% (announced its pivotal Phase 2/3 Illuminate trial of sepofarsen for the treatment of CEP290-mediated Leber congenital amaurosis 10 (LCA10) did not meet its primary endpoint )
- TWST -6.2% (prices offering of 4545454 shares of its common stock at $55.00 per share)
- PHUN -2.5% (files for 4.2 mln share common stock offering by selling shareholder)
- PDCE -2% (to move to S&P MidCap 400 from S&P SmallCap 600)
- LFG -1.2% (CFO to step down)
- EXC -1% (chairman to retire)
Analyst comments:
- TXN -1.2% (downgraded to Hold from Buy at Edward Jones)
- CDAY -0.9% (downgraded to Underperform from Peer Perform at Wolfe Research)